Drug eluting versus bare metal stents in cardiac allograft vasculopathy

Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy

(2010) Michael S. Lee et al.   JACC-Cardiovascular Interventions

Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes

(2010) Giuseppe Tarantini et al.   Journal of Cardiovascular Medicine

Percutaneous Coronary Interventions in Cardiac Allograft Vasculopathy: A Single-Center Experience

(2010) P. Colombo et al.   TRANSPLANTATION PROCEEDINGS

Value of Drug-Eluting Stents in Cardiac Transplant Recipients

(2009) Anuj Gupta et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy

(2009) Tonga Nfor et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report—2009

(2009) David O. Taylor et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy

(2008) Michael S. Lee et al.   JACC-Cardiovascular Interventions

Outcomes of Bare Metal versus Drug-eluting Stents in Allograft Vasculopathy

(2008) Proddutur R. Reddy et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A Decade of Percutaneous Coronary Interventions in Cardiac Transplant Recipients: A Monocentric Study in 160 Patients

(2008) Ernst Wellnhofer et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION